This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hawkins, E. F. Articles by Markland, F. S. Search for Related Content PubMed PubMed Citation Articles by Hawkins, E. F. Articles by Markland, F. S., Jr.

Receptor for Glucocorticoids in RPMI 3460 Melanoma Cells¹

Department of Physiology and Biophysics [E. F. H.], Department of Biochemistry [F. S. M.], and the LAC-USC Comprehensive Cancer Center [E. F. H., F. S. M.], University of Southern California, School of Medicine, Los Angeles 90033, and Molecular Biology Division, University of Southern California, Los Angeles, California 90007 [D. H.]

We are investigating the role of steroid hormones in the biological behavior of malignant melanoma. We have recently shown that the growth of RPMI 3460 Syrian hamster melanoma cells in monolayer culture is retarded by the synthetic glucocorticoid dexamethasone. This paper reports the identification of a macromolecule with properties of a glucocorticoid receptor in cytosols prepared from these cells. Sucrose density gradient analyses on six separate cell batches consistently demonstrated substantial levels of saturable [³H]dexamethasone binding [concentration = 195 ± 47 (S.E.) fmol/mg cytosol protein] in the 7S region of the gradients. Similar analyses failed to detect saturable binding for other classes of steroid hormones. Scatchard plots of [³H]dexamethasone binding to the receptor were linear, indicating a single class of high-affinity sites (K_d = 2.3 ± 0.78 x 10^-9 M for three cell batches). Steroid competition experiments confirmed the glucocorticoid specificity of the binding molecule; competitors in descending order of effectiveness were glucocorticoids, mineralocorticoid, progestins, estrogen, and androgen.

Combined hormone receptor and growth studies with RPMI 3460 cells can help to define the mechanism of glucocorticoid action in malignant melanoma and may ultimately help establish the value of steroid hormones as therapeutic agents for this disease.

¹ Supported by NIH Grant CA14089, by American Cancer Society Institutional Research Grants IN-21-R and IN-21-S to the LAC-USC Comprehensive Cancer Center, and by a Basil O'Connor Starter Research Grant from the National Foundation March of Dimes.

² To whom requests for reprints should be addressed, at University of Southern California, Research Building 1, Room 245, 1720 Zonal Ave., Los Angeles, Calif. 90033.

Received 1/22/80. Accepted 3/20/80.

This article has been cited by other articles:

				F. J. Collinson, T. K. Lam, W. M. J. Bruijn, J. H. W. de Wilt, M. Lamont, J. F. Thompson, and R. F. Kefford Long-term Survival and Occasional Regression of Distant Melanoma Metastases after Adrenal Metastasectomy Ann. Surg. Oncol., June 1, 2008; 15(6): 1741 - 1749. [Abstract] [Full Text] [PDF]